Topic: Crossover Designs

Confounding Among Sequence, Period, and Treatment

Counting Treatment Exposures Per Participant

Covariance Between Repeated Formulation Responses

Crossover Schedule Review: A Design Checklist

Choosing Between Two-Period and Replicate Designs

Choosing Washout Duration From Drug Half-Life

Blinding and Treatment Presentation Across Periods

Carryover Risks in Replicate Schedules

Auditing Treatment Transitions in a Crossover Schedule

Balancing Full-Replicate Sequence Groups